Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer
Chuling Hu,1,* Yan Liu,2,* Wei Cao,3,* Na Li,4 Shen Gao,5 Zhuo Wang,5 Fenfen Gu2 1Department of Pharmacy, Jiaxing Maternity and Child Health Care Hospital, Affiliated Women and Children’s Hospital of Jiaxing University, Jiaxing, People’s Republic of China; 2Department of Clin...
Main Authors: | Hu C, Liu Y, Cao W, Li N, Gao S, Wang Z, Gu F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-01-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-mechanism-of-a-biomimetic-nanosystem-carrying-doxorubicin-peer-reviewed-fulltext-article-IJN |
Similar Items
-
Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer
by: Liu Jia, et al.
Published: (2023-08-01) -
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis
by: Stephen G. Smoots, et al.
Published: (2024-03-01) -
Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
by: Jameson T.L. Berry, et al.
Published: (2020-09-01) -
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
by: Sandra Torres-Ruiz, et al.
Published: (2023-02-01) -
Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer
by: Alaa Bawaneh, et al.
Published: (2022-10-01)